Chevron stock price holds near $167 after Tengiz outage update — what CVX investors watch next week
24 January 2026
1 min read

Chevron stock price holds near $167 after Tengiz outage update — what CVX investors watch next week

New York, January 23, 2026, 20:39 EST — The market has closed.

Shares of Chevron (CVX) closed Friday slightly higher, up 0.04% at $166.72. The company confirmed oil production at Kazakhstan’s massive Tengiz field remains offline after a fire forced a shutdown, highlighting ongoing supply concerns that could influence crude prices. 1

Chevron faces a tricky balance on Monday. Rising oil prices could boost upstream cash flow, but a prolonged outage at a key asset risks cutting volumes. Throw in a U.S. winter storm and new legal developments, and traders will be juggling more than just crude when the market opens.

Oil prices closed at their highest level in over a week on Friday, following U.S. sanctions targeting ships and companies that transport Iranian oil. The U.S. also announced a deployment of warships to the Middle East. Brent crude ended the day at $65.88 a barrel, while U.S. West Texas Intermediate finished at $61.07. 2

Chevron’s update on Tengiz highlights two bottlenecks in Kazakhstan. The government has launched a commission to probe the incident, while Tengizchevroil, the operator, declared force majeure on CPC Blend shipments, Reuters reports. 3

Winter storm Fern is forecast to bring freezing conditions across much of the U.S. through Monday, potentially forcing crude production shut-ins near 300,000 barrels per day, analysts say. “There is the potential for a surge in distillate demand,” noted oil analyst Tom Kloza, pointing to diesel and heating fuel needs. 4

Chevron is now grappling with fresh legal trouble. On Friday, Michigan Attorney General Dana Nessel launched an antitrust lawsuit targeting BP, Chevron, Exxon Mobil, Shell, and the American Petroleum Institute. The suit accuses them of colluding to block competition from renewables and electric vehicles. Chevron’s attorney, Theodore Boutrous Jr., dismissed the case as baseless and argued it overlooks Michigan’s dependence on oil and gas. 5

The risk case is complicated. Should Tengiz remain offline longer than anticipated, volume losses could surface swiftly, while a drop in crude prices would simultaneously chip away at any buffer. Conversely, supply shocks might ease quickly if repairs progress or geopolitical tensions cool off.

For the moment, the near-term trade boils down to oil prices and the latest snippets on Kazakhstan’s restart schedule, along with outages in the U.S. caused by weather. Legal battles usually drag on, but on days when energy stocks are shaky, they can still weigh on sentiment.

Chevron is set to report its quarterly earnings during a conference call on Friday, January 30, at 11:00 a.m. ET. CEO Mike Wirth and CFO Eimear Bonner will lead the discussion. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Lumentum stock drops 4% even as Citi, Stifel boost targets ahead of earnings
Previous Story

Lumentum stock drops 4% even as Citi, Stifel boost targets ahead of earnings

GE Vernova stock: Power-unit CEO exit lands days before earnings
Next Story

GE Vernova stock: Power-unit CEO exit lands days before earnings

Go toTop